EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference to be held on September 11-13, 2011 at The Waldorf=Astoria Hotel in New York.
